1. Market Research
  2. > Pathology
About 100 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Global Liver Disease Treatment Market 2017-2021

  • $ 2500
  • July 2017
  • 98 pages

TECHNAVIO.

  • Digestive System Disorder
  • Therapy
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.

Toll Like Receptor 4 - Pipeline Review, H2 2019

  • $ 3500
  • August 2019
  • 117 pages

Key data to be presented: lymphoma and melanoma preclinical models.

  • Digestive System Disorder
  • Hospital
  • Lymphoma
  • Therapy
  • TaiwanJ Pharmaceuticals Co., Ltd.

Microbiome Therapeutics and Diagnostics Market (2nd Edition), 2017 - 2030

  • $ 2499
  • July 2017
  • 450 pages

` Sample Pages Microbiome Therapeutics and Diagnostics Market (##nd Edition), 2017-2030 2017 THIS PAGE IS INTENTIONALLY LEFT BLANK Copyright © 2017 Roots Analysis Private Ltd.

  • Digestive System Disorder
  • Pharmaceutical
  • Therapy
  • North America
  • United States

Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape

  • $ 4995
  • September 2016
  • 1 pages

Patients may also have an increased risk of developing lymphomas and other malignancies, and onset or worsening of congestive heart failure.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Lymphoma
  • Pharmaceutical
  • Therapy

Gilead Sciences Inc (GILD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 285 pages

Specific types include large B-cell lymphoma (DLBCL), primary mediastinal large B-cell lymphoma (PMBCL), high-grade B-cell lymphoma, and DLBCL arising from follicular lymphoma (transformed follicular lymphoma, or TFL).

  • Digestive System Disorder
  • HIV AIDS
  • Lymphoma
  • Pharmaceutical
  • Therapy

Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H1 2019

  • $ 3500
  • March 2019
  • 46 pages

Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H1 2019 Summary Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) ...

  • Digestive System Disorder
  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States

Liver Failure (Hepatic Insufficiency) Global Clinical Trials Review, H1, 2020

  • $ 2500
  • January 2020
  • 306 pages

Lymphomas with Hepatic Dysfunction Tazemetostat in Treating Patients with Metastatic or Unresectable Solid Tumors or B-cell Lymphomas with Liver Dysfunction GDCT## NCT##, NCI-2017-##; ##; UM##CA##; PJC-## Gastrointestinal B-Cell Non-Hodgkin Lymphoma, Hepatocellula

  • Clinical Trial
  • Digestive System Disorder
  • Lymphoma
  • Pharmaceutical
  • Therapy

Epiomic Epidemiology Series: Crohn’s Disease Forecast in 12 Major Markets 2017-2027

  • $ 4087
  • January 2017
  • 68 pages

Risk of lymphoma associated with combination anti-tumour necrosis factor and immunomodulator therapy for the treatment of Crohn' s disease: a meta-analysis.

  • Digestive System Disorder
  • Healthcare
  • Lymphoma
  • Pathology

Intercellular Adhesion Molecule 1 - Pipeline Review, H2 2019

  • $ 3500
  • August 2019
  • 47 pages

Intercellular Adhesion Molecule 1 - Pipeline Review, H2 2019 Summary Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Intercellular Adhesion Molecule 1 (ICAM-1) is ...

  • Digestive System Disorder
  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States

Tumor Necrosis Factor Receptor Superfamily Member 10B - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 81 pages

It was under development for the treatment of advanced solid tumors, lymphomas, and metastatic colorectal cancer.

  • Biotechnology
  • Digestive System Disorder
  • Lymphoma
  • Therapy
  • Genmab group

Gastritis Global Clinical Trials Review, H1, 2020

  • $ 2500
  • May 2020
  • 207 pages

Pylori GDCT## NCT##, KCT##; 2018-##-##-## Gastrointestinal Atrophic Gastritis, Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue or MALT- Lymphoma), Gastric Cancer, Helicobacter pylori Infections Ongoing, recruiting Phase III Interventiona

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Lymphoma
  • Therapy

Biopsy Devices - Medical Devices Pipeline Assessment, 2020

  • $ 4000
  • March 2020
  • 236 pages

Biopsy Devices - Medical Devices Pipeline Assessment, 2020SummaryThe Medical Devices sector report, “Biopsy Devices - Medical Devices Pipeline Assessment, 2020" provides an overview of Biopsy Devices ...

  • Biopsy
  • Clinical Trial
  • Digestive System Disorder
  • Injectable Delivery
  • Magnetic Resonance Imaging

Liver Failure (Hepatic Insufficiency) - Pipeline Review, H2 2019

  • $ 2000
  • December 2019
  • 98 pages

The drug candidate is in Phase I/ II stage of development for the treatment of angioimmunoblastic Tcell lymphoma (AITL), glioma, solid tumor, intrahepatic cholangiocarcinoma, acute myeloid leukemia (first line), hematological tumor and chondrosarcoma.

  • Digestive System Disorder
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • United States

Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE Like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) - Pipeline Review, H2 2018

  • $ 3500
  • August 2018
  • 74 pages

It was also under development for advanced solid tumor malignancies or lymphoma.

  • Chemotherapy
  • Digestive System Disorder
  • Lymphoma
  • Therapy
  • BeyondSpring Pharmaceuticals Inc.

Plasminogen Activator Inhibitor 1 - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 70 pages

lymphoma (DLBCL) receiving CAR T-cell therapy.

  • Digestive System Disorder
  • In Vitro Diagnostic Reagent
  • Lymphoma
  • Pharmaceutical
  • Therapy

Celiac Disease - Pipeline Review, H1 2020

  • $ 2000
  • March 2020
  • 85 pages

Celiac Disease - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Celiac Disease - Pipeline Review, H1 2020, provides an overview of the Celiac Disease ...

  • Biopharmaceutical
  • Digestive System Disorder
  • Pathology
  • Therapy
  • United States

Duodenal Ulcer Global Clinical Trials Review, H1, 2020

  • $ 2500
  • May 2020
  • 295 pages

Lymphoma Kinase or CD## or ALK or EC ##. ##. ##. ##) Inhibitor; Hepatocyte Growth Factor Receptor (Proto Oncogene c Met or Tyrosine Protein Kinase Met or HGF/ SF Receptor or Scatter Factor Receptor or MET or EC ##. ##. ##. ##) Inhibitor; Macrophage Stimulating Protein Receptor (CDw## or Protein T

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Lymphoma
  • Therapy

Galectin 3 (35 kDa Lectin or Carbohydrate Binding Protein 35 or Galactose Specific Lectin 3 or Galactoside Binding Protein or IgE Binding Protein or Laminin Binding Proteinor Mac 2 Antigen or LGALS3) - Pipeline Review, H1 2018

  • $ 3500
  • June 2018
  • 70 pages

Galectin 3 (35 kDa Lectin or Carbohydrate Binding Protein 35 or Galactose Specific Lectin 3 or Galactoside Binding Protein or IgE Binding Protein or Laminin Binding Proteinor Mac 2 Antigen or LGALS3) - ...

  • Digestive System Disorder
  • Hospital
  • Therapy
  • Product Initiative
  • Galectin Therapeutics Inc.

Caspase 8 - Pipeline Review, H1 2018

  • $ 3500
  • January 2018
  • 61 pages

It was also under development for advanced solid tumor malignancies or lymphoma.

  • Chemotherapy
  • Digestive System Disorder
  • Lymphoma
  • Therapy
  • Conatus Pharmaceuticals Inc.

Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2020

  • $ 2000
  • June 2020
  • 103 pages

Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Liver Failure - Pipeline Review, H1 2020, provides an overview ...

  • Digestive System Disorder
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Promethera Biosciences S.A.
View report >

Digestive System Disorder Statistics in California (USA)

  • November 2018
  • 37 pages

Lymphoma, non Hodgkin; ## Myelodysplasia; ## Myelofibrosis; ## Nasopharynx; ## Renal; ## Anus; ## Brain; ## Breast; ## Duodenum; ## Hodgkin Lymphoma; ## Hypopharynx; ## Leukemia-Acute Lymphoblastic; ## Leukemia-Acute Monocytic; ## Mesothelioma; ## Rectum; ## Synovial Sarcoma; ## Testes; ## Tonsil ## POSSIBLY

  • Digestive System Disorder
  • Healthcare
  • Hospital
  • Pathology
  • United States

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on